Busmion, Romeo, JR.. M.

HRN: 00-13-66  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2024
CEFTRIAXONE 1G (VIAL)
02/01/2024
02/08/2024
IV
2 Grams
Once Daily
Multiple Soft Tissue Injury Secondary To MVA ( 2 Wheel, Driver, Collision); Rule Out Fracture, Right Leg
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: